• Generic name: Ticagrelor
  • Pharmacologic Category: Antiplatelet agent
  • Dosage Forms: Tablet, Oral (60 mg ,90 mg )
  • Patients with acute coronary syndrome (ACS) or a history of myocardial infarction
  • Patients with coronary artery disease (CAD) at high risk for ischemic events
  • Patients with acute ischemic stroke (NIHSS ≤5) or high-risk transient ischemic attack (TIA)

About Ticalix:

Ticagrelor and its major metabolite reversibly interact with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent.


Did you know . . . ???!

Did you know, every 2.5 minutes, one heart attack occurred again for patients
who have survived from prior myocardial infarction?
Ticagrelor remarkably reduces the rate of death from cardiovascular
events, myocardial infarction or stroke and recurrent cardiovascular events


دی ان ان